adenosine monophosphate has been researched along with Bradycardia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 18 (94.74) | 2.80 |
| Authors | Studies |
|---|---|
| Ching, PR; Lee, C | 1 |
| Apostolidou, S; Avataneo, V; Kobbe, R; Rau, C; Singer, D | 1 |
| Bistrovic, P; Lucijanic, M; Manola, S | 1 |
| Bistrovic, P; Lucijanic, M | 2 |
| Drolet, B; Pilote, S; Simard, C | 1 |
| Ahsan, CH; Al-Taweel, O; Batra, K; Bauzon, JS; Cosme, C; Diep, J; Go, A; Hawwass, D; Houshmand, N; Inciong, K; Lee, K; Mohammed, S; Nasser, K; Pham, U; Rana, J; Schreiber, A; Sossou, C | 1 |
| Calvo, C; Mendez-Echevarria, A; Sándor-Bajusz, KA | 1 |
| Gutierrez-Rosa, I; Rodriguez-Gonzalez, M; Sanchez-Codez, MI | 1 |
| Blanc, P; Esperti, S; Gabbuti, A; Mecocci, L; Pallotto, C; Suardi, LR | 1 |
| Abdel-Qadir, H; Day, LB; Fralick, M | 1 |
| Cebrián Lara, L; García Llopis, P; Hernàndez Lorente, E | 1 |
| Attala, L; Baragli, F; Blanc, P; Esperti, S; Esposti, AD; Francisci, D; Gabbuti, A; Mecocci, L; Pallotto, C; Pierotti, P; Pietro, MAD; Salomoni, E; Suardi, LR; Vichi, F | 1 |
| Chow, EJ; Kazmier, KM; Maust, B; Stokes, C | 1 |
| Albani, S; Attena, E; De Rosa, A; Fiorentino, G; Maraolo, AE; Mollica, M; Parrella, R; Pisapia, R; Russo, V; Severino, S | 1 |
| Dasoula, F; Dimopoulou, D; Eleftheriou, I; Krepis, P; Liaska, M; Spyridis, N; Tsolia, M | 1 |
| Arcuri, C; Aseri, M; Barve, P; Chaudhuri, S; Gupta, R; Kumar, S; Shah, S | 1 |
| Kamath, A; Singh, A | 1 |
| Garnham, B; Hack, B; Headrick, JP; Matherne, GP; Peart, J | 1 |
1 review(s) available for adenosine monophosphate and Bradycardia
| Article | Year |
|---|---|
Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bradycardia; Child; COVID-19 Drug Treatment; Humans; SARS-CoV-2 | 2021 |
18 other study(ies) available for adenosine monophosphate and Bradycardia
| Article | Year |
|---|---|
Remdesivir-associated bradycardia.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Bradycardia; COVID-19 Drug Treatment; Humans; Male; SARS-CoV-2 | 2021 |
Remdesivir, Sinus Bradycardia and Therapeutic Drug Monitoring in Children With Severe COVID-19.
Topics: Adenosine Monophosphate; Alanine; Bradycardia; Child; COVID-19 Drug Treatment; Drug Monitoring; Humans; SARS-CoV-2 | 2021 |
Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bradycardia; COVID-19 Drug Treatment; Humans; Retrospective Studies | 2022 |
Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bradycardia; COVID-19 Drug Treatment; Humans; Prognosis | 2022 |
Remdesivir (VEKLURY) for Treating COVID-19: Guinea Pig Ex Vivo and In Vivo Cardiac Electrophysiological Effects.
Topics: Action Potentials; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Bradycardia; COVID-19 Drug Treatment; Electrocardiography; Guinea Pigs; Long QT Syndrome; Male | 2022 |
Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Bradycardia; COVID-19 Drug Treatment; Humans; Male; Middle Aged; Retrospective Studies; SARS-CoV-2 | 2022 |
Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection-reply.
Topics: Adenosine Monophosphate; Alanine; Bradycardia; Child; COVID-19 Drug Treatment; Humans; SARS-CoV-2 | 2021 |
Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection.
Topics: Adenosine Monophosphate; Alanine; Bradycardia; Child; Compassionate Use Trials; COVID-19 Drug Treatment; Humans; SARS-CoV-2 | 2021 |
Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).
Topics: Adenosine Monophosphate; Aged; Alanine; Bradycardia; COVID-19; COVID-19 Drug Treatment; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; SARS-CoV-2; Treatment Outcome | 2021 |
Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bradycardia; COVID-19 Drug Treatment; Humans; Male; Middle Aged | 2021 |
Bradycardia due to remdesivir: Report of two cases.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bradycardia; Humans | 2022 |
Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
Topics: Adenosine Monophosphate; Alanine; Bradycardia; COVID-19 Drug Treatment; Humans; SARS-CoV-2 | 2021 |
Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.
Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Bradycardia; COVID-19; COVID-19 Drug Treatment; Female; Heart Rate; Hospitalization; Humans; Incidence; Italy; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors | 2021 |
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.
Topics: Adenosine Monophosphate; Alanine; Bradycardia; COVID-19 Drug Treatment; Electrocardiography; Humans; Pilot Projects; SARS-CoV-2 | 2021 |
Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.
Topics: Adenosine Monophosphate; Alanine; Bradycardia; Child; COVID-19 Drug Treatment; Humans; SARS-CoV-2 | 2021 |
Remdesivir therapy associated with Bradycardia in SARS-CoV2.
Topics: Adenosine Monophosphate; Alanine; Bradycardia; COVID-19 Drug Treatment; Humans; RNA, Viral; SARS-CoV-2 | 2021 |
Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
Topics: Acute Kidney Injury; Adenosine Monophosphate; Adverse Drug Reaction Reporting Systems; Alanine; Antiviral Agents; Bradycardia; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Liver Function Tests; Male; Middle Aged; SARS-CoV-2; United States; United States Food and Drug Administration | 2021 |
5'-Adenosine monophosphate and adenosine metabolism, and adenosine responses in mouse, rat and guinea pig heart.
Topics: Adenosine; Adenosine Monophosphate; Animals; Bradycardia; Calcium; Dose-Response Relationship, Drug; Guinea Pigs; Hemoglobins; Inosine; Mice; Models, Biological; Myocardial Contraction; Myocardium; Perfusion; Phosphorylation; Rats; Species Specificity | 2001 |